Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

HYDROXYUREA 500 MG CAPSULE

HYDROXYUREA
$0.1954per EA

Strength

500 mg/1

Manufacturer

Somerset Therapeutics, LLC

NDC

70069082001

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

HYDROXYUREA

Approval Type

Generic (ANDA)

FDA Application

ANDA218021

On Market Since

6/18/2024

Pharmacological Classes

Antimetabolite
Urea

Price History

1W

0.0%

1M

-1.9%

3M

-1.9%

6M

-4.0%

1Y

-5.3%

3Y

N/A

5Y

N/A

All

-21.1%

Generic Alternatives

1 alternative • Same active ingredient

HYDROXYUREA 500 MG CAPSULE
Generic
69315016401•Leading Pharma, LLC
$0.1954

Related Drugs

Same classification

AZATHIOPRINE 50 MG TABLET
Generic
16571083501•Rising Pharma Holdings Inc.
$0.1334
per EA
AZATHIOPRINE 50 MG TABLET
Generic
60219107601•Amneal Pharmaceuticals NY LLC
$0.1334
per EA
AZATHIOPRINE 50 MG TABLET
Generic
67877049301•Ascend Laboratories, LLC
$0.1334
per EA
AZATHIOPRINE 50 MG TABLET
Generic
67877049305•Ascend Laboratories, LLC
$0.1334
per EA
AZATHIOPRINE 50 MG TABLET
Generic
68084022901•American Health Packaging
$0.1334
per EA
AZATHIOPRINE 50 MG TABLET
Generic
68382000301•Zydus Pharmaceuticals (USA) Inc.
$0.1334
per EA
AZATHIOPRINE 50 MG TABLET
Generic
68382000305•Zydus Pharmaceuticals (USA) Inc.
$0.1334
per EA
AZATHIOPRINE 50 MG TABLET
Generic
68462050201•Glenmark Pharmaceuticals Inc., USA
$0.1334
per EA
HYDROXYUREA 500 MG CAPSULE
Generic
00555088202•Teva Pharmaceuticals USA Inc.
$0.1954
per EA
HYDROXYUREA 500 MG CAPSULE
Generic
00904693961•Major Pharmaceuticals
$0.1954
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy